Código QR (código de barras bidimensional)

Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesothelioma

Malignant pleural mesothelioma (MPM) is a rare and highly aggressive tumor. Nivolumab showed durable antitumor effect in patients with recurrent MPM and was approved for those patients in Japan in 2018. Immune related adverse event (irAE) is occurred in various organs and is suggestive to be related...

ver descrição completa

Na minha lista:
Principais autores: Jun Sakakibara-Konishi, Mineyoshi Sato, Michiko Takimoto Sato, Kohei Kasahara, Masahiro Onozawa, Hidenori Mizugaki, Eiki Kikuchi, Hajime Asahina, Naofumi Shinagawa, Satoshi Konno
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020-01-01
coleção:Respiratory Medicine Case Reports
Assuntos:
Malignant pleural mesothelioma
Nivolumab
Immune thrombocytopenia
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S221300712030383X
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados